Hepatic arterial infusion (HAI) of fixed dose rate gemcitabine in patients with liver metastases from colorectal carcinoma. A phase I study with pharmocokinetic analysis

被引：0
|
作者：
Leonard, Gregory D. [1 ]
Sperber, Daniella [1 ]
O'Connor, Owen [1 ]
Kemeny, Nancy E. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [1] A phase I study of hepatic arterial infusion (HAI) of irinotecan in patients with inoperable liver metastases of colorectal cancer.
    Vogl, TJ
    Eichler, K
    Mack, MG
    Balzer, JO
    Herzog, C
    Söllner, O
    Zangos, S
    Thalhammer, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 297S - 297S
  • [2] Phase I trial of fixed dose rate infusion (FDRI) gemcitabine (GEM) with gefitinib in patients with advanced pancreatic carcinoma.
    Carneiro, B
    Brand, R
    Fine, E
    Knop, R
    Khandekar, J
    Uhlig, W
    Locker, GY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 337S - 337S
  • [3] Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma
    Carneiro, Benedito A.
    Brand, Randall E.
    Fine, Elita
    Knop, Richard H.
    Khandekar, Janardan D.
    Uhlig, William
    Locker, Gershon Y.
    CANCER INVESTIGATION, 2007, 25 (05) : 366 - 371
  • [4] Hepatic Arterial Infusion with Irinotecan in Patients with Liver Metastases of Colorectal Cancer: Results of an Extended Phase I Study
    Eichler, K.
    Dufas, T.
    Hammerstingl, R.
    Gruber-Rouh, T.
    Vogl, T. J.
    Zangos, S.
    CHEMOTHERAPY, 2013, 59 (01) : 66 - 73
  • [5] Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer
    Furuse, J
    Ishii, H
    Okusaka, T
    Nagase, M
    Nakachi, K
    Ueno, H
    Ikeda, M
    Morizane, C
    Yoshino, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (12) : 733 - 738
  • [6] Phase I clinical and pharmacokinetic (PK) study of gemcitabine (GEM) given by hepatic arterial infusion (HAI)
    Vangroeningen, C
    Honeywell, R
    Peters, G
    Laan, A
    Ruyter, R
    Pinedo, H
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 295S - 295S
  • [7] Hepatic arterial infusion (HAI) of oxaliplatin combined with docetaxel and capecitabine in patients with liver metastases from non-colorectal gastrointestinal tumours: A dose-finding study
    Hernandez, A.
    Rodriguez, J.
    Viudez, A.
    Chopitea, A.
    Bandres, E.
    Zarate, R.
    Ponz-Sarvise, M.
    Olier, C.
    Reyna, C.
    Garcia-Foncillas, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A pharmacokinetic study of gemcitabine at fixed dose rate infusion in patients with impaired hepatic function
    Felici, A.
    Di Segni, S.
    Colantonio, S.
    Milella, M.
    Ciccarese, M.
    Cecere, F. L.
    Nuvoli, B.
    Ferretti, G.
    Citro, G.
    F, Cognetti
    ANNALS OF ONCOLOGY, 2006, 17 : XI28 - XI28
  • [9] Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program
    Liu, Annie
    Lowe, Melissa
    Niedzwiecki, Donna
    Rhodin, Kristen E.
    Sharib, Jeremy
    Wildman-Tobriner, Benjamin
    Wong, Terence Z.
    Kim, Charles Y.
    Thacker, Julie
    Mantyh, Christopher
    Migaly, John
    Lan, Billy Y.
    Strickler, John H.
    David Hsu, S.
    Nussbaum, Daniel
    Zani, Sabino
    Uronis, Hope
    Allen, Peter J.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 1033 - 1042
  • [10] A phase I study of hepatic intra-arterial chemotherapy with gemcitabine in patients with inoperable liver metastases
    Heller, M
    Eichler, K
    Schwarz, W
    Balzer, JO
    Mack, MG
    Vogl, TJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 352S - 352S
12345